☆ 4.5 Article

Inactivated COVID-19 vaccines: durability of Covaxin/BBV152 induced immunity against variants of concern

JOURNAL OF TRAVEL MEDICINE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Virology

Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines

Yusha Araf et al.

Summary: The Omicron variant of SARS-CoV-2 is a heavily mutated virus with a high risk of infection. Limited information is available regarding the genomics, transmissibility, and effectiveness of vaccines against this variant, emphasizing the need for further investigation.

JOURNAL OF MEDICAL VIROLOGY (2022)

添加到收藏夹

Article Medicine, General & Internal

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

Nicole Wolter et al.

Summary: According to data analysis from South Africa, individuals infected with the omicron variant have a lower likelihood of hospitalization compared to those infected with non-omicron variants. Furthermore, individuals infected with the omicron variant have a lower odds of severe disease compared to individuals infected with the earlier delta variant.

LANCET (2022)

添加到收藏夹

Editorial Material Public, Environmental & Occupational Health

Shorter serial intervals and incubation periods in SARS-CoV-2 variants than the SARS-CoV-2 ancestral strain

Zhanwei Du et al.

JOURNAL OF TRAVEL MEDICINE (2022)

添加到收藏夹

Letter Public, Environmental & Occupational Health

The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta

Ying Liu et al.

JOURNAL OF TRAVEL MEDICINE (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Booster dose of the inactivated COVID-19 vaccine BBV152 (Covaxin) enhances the neutralizing antibody response against Alpha, Beta, Delta and Omicron variants of concern

Gururaj Rao Deshpande et al.

Summary: The neutralizing antibody responses significantly increased after the third dose of BBV152/Covaxin against B.1 (19.11-fold), Delta (16.51-fold), Beta (14.70-fold), and Omicron (18.53-fold) Variants of concern, compared to the two-dose vaccine, providing assurance of a protective immune response in recipients.

JOURNAL OF TRAVEL MEDICINE (2022)

添加到收藏夹

Article Infectious Diseases

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Raches Ella et al.

Summary: The BBV152 vaccine demonstrated tolerable safety outcomes and enhanced immune responses in this clinical trial, leading to selection of both Algel-IMDG formulations for phase 2 immunogenicity trials. Further efficacy trials are warranted to validate the vaccine's effectiveness.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Multidisciplinary Sciences

T cell response to SARS-CoV-2 infection in humans: A systematic review

Madhumita Shrotri et al.

Summary: The study found that COVID-19 patients exhibit T cell lymphopenia, which is positively correlated with disease severity, duration of RNA positivity, and non-survival. Those with severe or critical disease tend to develop more robust, virus-specific T cell responses. Cross-reactive T cell responses have been demonstrated in unexposed and uninfected adults, but their significance for protection and susceptibility remains unclear.

PLOS ONE (2021)

添加到收藏夹

Letter Public, Environmental & Occupational Health

Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin

Rajni Kant et al.

JOURNAL OF TRAVEL MEDICINE (2021)

添加到收藏夹

Letter Public, Environmental & Occupational Health

Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152

Pragya D. Yadav et al.

JOURNAL OF TRAVEL MEDICINE (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic

Salim S. Abdool Karim et al.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial

Raches Ella et al.

Summary: The study reported the clinical efficacy of the BBV152 vaccine against COVID-19 infection in Indian adults. The vaccine demonstrated high efficacy in preventing laboratory-confirmed symptomatic COVID-19 and was well tolerated with no safety concerns raised in this interim analysis.

LANCET (2021)

添加到收藏夹

Article Infectious Diseases

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Raches Ella et al.

Summary: BBV152 vaccine, consisting of whole-virion inactivated SARS-CoV-2 with Algel and IMDG, showed high neutralizing antibody responses in phase 1 trial and better reactogenicity in phase 2 trial. The 6 mu g with Algel-IMDG formulation has been chosen for phase 3 efficacy trial.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Detection of a SARS-CoV-2 variant of concern in South Africa

Houriiyah Tegally et al.

Summary: The article describes a newly emerged lineage of SARS-CoV-2, 501Y.V2, characterized by eight mutations in the spike protein, which may result in increased transmissibility or immune escape. This lineage originated in South Africa and quickly became dominant in Eastern Cape, Western Cape, and KwaZuluNatal provinces within weeks.

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Nicholas G. Davies et al.

Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.

SCIENCE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques

Pragya D. Yadav et al.

Summary: This study demonstrates the protective efficacy and immunogenicity of the inactivated SARS-CoV-2 vaccine BBV152 in rhesus macaques, indicating that the vaccine candidate is in clinical development.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation

Brunda Ganneru et al.

Summary: The study reports the development and evaluation of a whole virion inactivated COVID-19 vaccine, showing high antigen-binding and neutralizing antibody titers in mice, rats, and rabbits, with excellent safety profiles.

ISCIENCE (2021)

添加到收藏夹

Editorial Material Medicine, Research & Experimental

COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic

Khan Sharun et al.

Summary: Wealthy countries have secured 60% of COVID-19 vaccine supplies, with some preordering enough doses to vaccinate their populations multiple times. India's Vaccine Maitri initiative aims to provide doses to low-income countries, emphasizing equitable access to vaccines is crucial for global vaccination coverage. Manufacturing affordable vaccines and exporting large consignments worldwide will help meet global vaccine needs.

ARCHIVES OF MEDICAL RESEARCH (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

Nicholas G. Davies et al.

Summary: Studies have shown that the SARS-CoV-2 B.1.1.7 lineage is more transmissible and may cause more severe illness compared to pre-existing variants.

NATURE (2021)

添加到收藏夹

Editorial Material Public, Environmental & Occupational Health

Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin

Pragya D. Yadav et al.

JOURNAL OF TRAVEL MEDICINE (2021)

添加到收藏夹

Review Genetics & Heredity

COVID-19 and SARS-CoV-2 Variants: Current Challenges and Health Concern

Md. Zeyaullah et al.

Summary: The COVID-19 outbreak originated in Wuhan, China and quickly spread globally, challenging the current global health system. The virus displays high infectivity and pathogenicity, similar to common cold symptoms, with limited treatment options. Researchers are now focusing on monitoring viral variants and their impact on vaccine efficacy.

FRONTIERS IN GENETICS (2021)

添加到收藏夹

Article Immunology

Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

Manish Sadarangani et al.

Summary: Most COVID-19 vaccines aim to induce immune responses, particularly neutralizing antibodies (NAbs), against the spike protein of the virus. mRNA vaccines have shown efficacy after just one dose, while adenovirus vaccines elicit polyfunctional antibodies and strong T cell responses. These findings suggest that protection may not solely rely on NAbs but also involve other immune effector mechanisms.

NATURE REVIEWS IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Jasper Fuk-Woo Chan et al.

LANCET (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Tracking the spread of COVID-19 in India via social networks in the early phase of the pandemic

Smite Azad et al.

JOURNAL OF TRAVEL MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Nina Le Bert et al.

NATURE (2020)

添加到收藏夹

Review Physiology

COVID-19 and the Immune System

Jan Paces et al.

PHYSIOLOGICAL RESEARCH (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

Divij Mathew et al.

SCIENCE (2020)

添加到收藏夹

Editorial Material Immunology

India's cost-effective COVID-19 vaccine development initiatives

Chiranjib Chakraborty et al.

VACCINE (2020)

添加到收藏夹

Review Multidisciplinary Sciences

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

Angkana T. Huang et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Allergy

Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways

Victoria J. Philbin et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

添加到收藏夹

Article Multidisciplinary Sciences

Potent Adjuvanticity of a Pure TLR7-Agonistic Imidazoquinoline Dendrimer

Nikunj M. Shukla et al.

PLOS ONE (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.